A multicenter prospective non-randomized phase II study of bi-weekly Irinotecan vs Raltitrexed as first line chemotherapy in elderly patients with metastatic colorectal cancer
ANNALS OF ONCOLOGY(2004)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要